Loteprednol Etabonate
02.16.21
Kala Pharmaceuticals Announces Eysuvis Now Covered by Express ScriptsSource: Kala Pharmaceuticals
01.07.21
Kala Pharmaceuticals Announces Commercial Availability of Eysuvis for the Treatment of Dry Eye DiseaseSource: Kala Pharmaceuticals
11.16.20
Kala Pharmaceuticals Provides Update on Launch Plans for Eysuvis for the Treatment of Dry Eye DiseaseSource: Kala Pharmaceuticals
10.27.20
Kala Pharmaceuticals Receives FDA Approval of Dry Eye Disease Treatment EysuvisSource: Kala Pharmaceuticals
05.26.20
Kala Pharmaceuticals Files New Drug Application to FDA for Eysuvis for Dry Eye DiseaseSource: Kala Pharmaceuticals
05.04.20
Kala Pharmaceuticals Resubmits NDA for Eysuvis for Dry Eye DiseaseSource: Kala Pharmaceuticals
03.09.20
Kala Pharmaceuticals Announces Statistically Significant Results in STRIDE 3 Trial of Dry Eye Disease Drug EysuvisSource: Kala Pharmaceuticals